CROFounded 2023
Fortrea
Durham, North Carolina, United States
Full-service global CRO offering phase I-IV clinical trial and biopharmaceutical development services, operating as an independent public company after being spun out of Labcorp's former Drug Development division.
- Segment
- CRO
- Headquarters
- Durham, North Carolina, United States
- Founded
- 2023
- Website
- www.fortrea.com
Notable facts
- Spun off from Labcorp as an independent company in July 2023, with shares distributed to Labcorp stockholders on June 30, 2023 and the company beginning to trade on Nasdaq under ticker FTRE.
- Traces its corporate lineage through Environmental Sciences Corporation (founded 1968), Hazleton, and Corning Lab Services to Covance (renamed 1996), which Labcorp acquired in 2015 and renamed Labcorp Drug Development in 2021 before the 2023 spin-off.
- Reported 2024 revenue of about $2.696 billion with roughly 15,500 employees operating in more than 90 countries.
- States it conducted more than 5,850 clinical trials over the five years ending 2023.
Sourcing guides
Sources. This profile is compiled from public reference data, WebSearch-verified against source 1 · source 2. Data as of 2026-07-14. See methodology.
Sourcing a vendor in this segment today? We connect clinical operations, regulatory, and procurement teams with qualified cro vendors.
Request vendors